Abstract:Hepatic stellate cells (HSCs) are the major site of vitamin A (retinol) esterification and subsequent storage as retinyl esters within lipid droplets. However, retinyl esters become depleted in many pathophysiological states, including acute and chronic liver injuries. Recently, using a liver slice culture system as a model of acute liver injury and fibrogenesis, a time-dependent increase and decrease in the apparent formation of the bioactive retinoid all-trans-retinoic acid (atRA) and retinyl palmitate was measured, respectively. This coincided with temporal changes in the gene expression of retinoid-metabolizing enzymes and binding proteins, that preceded HSC activation. However, the underlying mechanisms that promote early changes in retinoid metabolism remain unresolved. We hypothesized that LX-2 cells could be applied to investigate differences in quiescent and activated HSC retinoid metabolism. We demonstrate that the hypermetabolic state of activated stellate cells relative to quiescent stellate cells may be attributed to induction of STRA6, RBP4, and CYP26A1, thereby reducing intracellular concentrations of atRA. We further hypothesized that paracrine and autocrine cytokine signaling regulates HSC vitamin A metabolism in both quiescent and activated cells. In quiescent cells, tumor necrosis factor α dose-dependently downregulated LRAT and CRBP1 mRNA, with EC50 values of 30-50 pg/mL. Likewise, interleukin-1β decreased LRAT and CRBP1 gene expression but with less potency. In activated stellate cells, multiple enzymes were downregulated, suggesting that the full effects of altered hepatic vitamin A metabolism in chronic conditions require both paracrine and autocrine signaling events. Further, this study suggests the potential for cell type-specific autocrine effects in hepatic retinoid signaling. SIGNIFICANCE STATEMENT: HSCs are the major site of vitamin A storage and important determinants of retinol metabolism during liver fibrogenesis. Here, two LX-2 culture methods were applied as models of hepatic retinoid metabolism to demonstrate the effects of activation status and dose-dependent cytokine exposure on the expression of genes involved in retinoid metabolism. This study suggests that compared to quiescent cells, activated HSCs are hypermetabolic and have reduced apparent formation of retinoic acid, which may alter downstream retinoic acid signaling.

Roles of the Lipid Metabolism in Hepatic Stellate Cells Activation

Lipid droplets, the Holy Grail of hepatic stellate cells: In health and hepatic fibrosis

Regulatory Long Non-Coding RNAs of Hepatic Stellate Cells in Liver Fibrosis (Review)

Metabolic Hallmarks of Hepatic Stellate Cells in Liver Fibrosis

Hepatic Stellate Cell: A Double-Edged Sword in the Liver

Mechanisms of hepatic stellate cell activation

Molecular mechanism of hepatic stellate cell activation and antifibrotic therapeutic strategies

Signal Transduction of Hepatic Stellate Cells in Liver Fibrosis

Crosstalk between hepatic stellate cells and surrounding cells in hepatic fibrosis

Pathophysiological mechanisms of hepatic stellate cells activation in liver fibrosis

Hepatic stellate cell lipid droplets: a specialized lipid droplet for retinoid storage

From Basic Science towards Clinical Progress, Focusing on the Central Role of Hepatic Stellate Cells

Roles of hepatic stellate cells in acute liver failure: From the perspective of inflammation and fibrosis

Cytokine Receptors and Signaling in Hepatic Stellate Cells

Immunological characteristics of hepatic stellate cells

LX-2 Stellate Cells Are a Model System for Investigating the Regulation of Hepatic Vitamin A Metabolism and Respond to Tumor Necrosis Factor α and Interleukin 1 β

Targeted Lipidomics Analysis of Lysine 179 Acetylation of ACSF2 in Rat Hepatic Stellate Cells.

Autophagy and Exosomes: Cross-Regulated Pathways Playing Major Roles in Hepatic Stellate Cells Activation and Liver Fibrosis

[Update on isolation and functional research of hepatic stellate cells]